|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.30 CHF | -1.27% |
|
-2.91% | +13.41% |
| 07-08 | Lancelot Sweden fell 0.8% in June, BioArctic slid despite Eli Lilly deal | FW |
| 07-07 | US FDA approves Vera's kidney disease drug | RE |
| Market Cap | 285B 249B 230B 212B 403B 27,167B 410B 2,750B 1,078B 13,341B 1,068B 1,045B 46,210B | P/E 2026 * |
21.7x | P/E 2027 * | 18.4x |
|---|---|---|---|---|---|
| Enterprise Value | 317B 277B 255B 236B 449B 30,224B 456B 3,059B 1,199B 14,842B 1,189B 1,163B 51,410B | EV / Sales 2026 * |
5.57x | EV / Sales 2027 * | 5.19x |
| Free-Float |
91.66% | Yield 2026 * |
2.83% | Yield 2027 * | 2.93% |
Last Transcript: Novartis AG
| 1 day | -1.11% | ||
| 1 week | -2.91% | ||
| Current month | -1.80% | ||
| 1 month | +5.00% | ||
| 3 months | +1.74% | ||
| 6 months | +9.00% | ||
| Current year | +13.41% |
| 1 week | 124.2 |  | 128.7 |
| 1 month | 117.64 | | 128.92 |
| Current year | 107.68 | | 131 |
| 1 year | 91.2 | | 131 |
| 3 years | 81.1 | | 131 |
| 5 years | 72.84 | | 131 |
| 10 years | 65.09 | | 131 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 01/02/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 16/03/2026 |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 64 | 16/05/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 01/01/2015 |
| Director/Board Member | 69 | 01/01/2016 | |
Ton Büchner
BRD | Director/Board Member | 61 | 01/01/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-18 | Sell | -5,200 | 0.0003% | |||
| 05-04 | Sell | 6,800 | 0.0003% | |||
| 02-17 | Sell | 30,743 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.27% | -2.91% | +27.42% | +44.91% | 285B | |
| -0.73% | -0.80% | +53.03% | +165.74% | 1,084B | |
| -1.28% | -0.97% | +66.68% | +63.31% | 634B | |
| -0.84% | -3.97% | +31.52% | +86.40% | 447B | |
| +0.18% | -1.76% | +29.04% | +26.48% | 330B | |
| -6.22% | -8.14% | +28.87% | +31.18% | 295B | |
| -0.93% | -3.57% | -27.74% | -39.70% | 218B | |
| -1.54% | -3.14% | +22.21% | +61.26% | 199B | |
| -1.71% | +1.83% | +18.04% | +76.60% | 169B | |
| +0.73% | -0.27% | -5.11% | -32.02% | 137B | |
| Average | -1.35% | +2.34% | +24.40% | +48.42% | 379.69B | |
| Weighted average by Cap. | -1.26% | +2.42% | +36.99% | +79.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 56.87B 49.75B 45.87B 42.45B 80.56B 5,428B 81.91B 549B 215B 2,665B 213B 209B 9,233B | 60.31B 52.76B 48.65B 45.02B 85.44B 5,757B 86.87B 583B 228B 2,827B 226B 222B 9,792B |
| Net income | 14.1B 12.34B 11.38B 10.53B 19.98B 1,346B 20.32B 136B 53.41B 661B 52.95B 51.8B 2,290B | 15.65B 13.69B 12.62B 11.68B 22.17B 1,494B 22.54B 151B 59.26B 733B 58.74B 57.47B 2,541B |
| Net Debt | 32.03B 28.02B 25.84B 23.9B 45.37B 3,057B 46.13B 309B 121B 1,501B 120B 118B 5,200B | 28.54B 24.96B 23.02B 21.3B 40.43B 2,724B 41.1B 276B 108B 1,338B 107B 105B 4,633B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/07/26 | CHF 124.30 | -1.27% | 2,233,204 |
| 08/07/26 | CHF 125.90 | -0.71% | 2,243,169 |
| 07/07/26 | CHF 126.80 | +1.36% | 2,306,045 |
| 06/07/26 | CHF 125.10 | -2.20% | 2,283,429 |
| 03/07/26 | CHF 127.92 | -0.08% | 1,776,406 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
